| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Coleman Mark serves as a Director at AXSM. Across recent SEC filings that breaks down to 11 buys and 12 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Coleman Mark's trades have earned a below-average insider score of 37/100 across 9 rated trades. Over a 12-month horizon, 12.5% of those trades were profitable, with an average 12-month return of -49.4%.
The biggest single holding is AXSM (~$7.6M) as Director. The recent filings there lean toward selling, a net 63,660 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Director | Sale+OE | 643 | $249.00 | $160,107.00 | -2.1% | -15.6% | - | |
| Jun 2, 2026 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 17,537 | $229.20 | $4,019,470.43 | -37.2% | -10.6% | - | |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 25,000 | $161.11 | $4,027,750.00 | -34.7% | +43.7% | - | |
| Sep 8, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 1,575 | $127.28 | $200,466.30 | +3.4% | +14.1% | +60.7% | |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 7,500 | $104.45 | $783,375.00 | -13.9% | +17.6% | +126.1% | |
| May 20, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 3,000 | $107.49 | $322,473.00 | -5.3% | +2.6% | +112.8% | |
| May 29, 2024 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 10,497 | $75.17 | $789,107.29 | -41.8% | +18.2% | +39.1% | |
| Sep 15, 2023 | AXSM Axsome Therapeutics, Inc. | Director | Sale+OE | 29,588 | $75.18 | $2,224,430.37 | -6.8% | -2.6% | +24.5% | |
| Nov 18, 2021 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 1,430 | $35.09 | $50,180.73 | +0.3% | -11.2% | +57.8% | |
| May 12, 2021 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 500 | $58.15 | $29,075.00 | +0.1% | -58.3% | -55.6% |